Lack of association between serum paraoxonase-1 activity and residual platelet aggregation during dual anti-platelet therapy

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Ohmori, Tsukasa ^a   Yano, Yuichiro ^a   Sakata, Asuka ^a   Ikemoto, Tomokazu ^a   Shimpo, Masahisa ^a   Madoiwa, Seiji ^a   Katsuki, Takaaki ^a   Mimuro, Jun ^a   Shimada, Kazuyuki ^a   Kario, Kazuomi ^a   Sakata, Yoichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

antiplatelet agent; coronary syndrome; platelet pharmacology

Indexed keywords

ACETYLSALICYLIC ACID; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; BRAIN NATRIURETIC PEPTIDE; HOMOCYSTEINE THIOLACTONE HYDROLASE; HYDROLASE; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; ANKLE BRACHIAL INDEX; ARTICLE; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; THROMBOCYTE AGGREGATION;

ACUTE CORONARY SYNDROME; ARYLDIALKYLPHOSPHATASE; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PYRIDINES; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 84858333716     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.10.033     Document Type: Article

References (22)

1. D. Alexopoulos Clopidogrel pretreatment in PCI: absolute requirement or obsolete myth? Int J Cardiol 146 2011 305 310
2. A.J. Farre, J. Tamargo, P.J. Mateos-Caceres, L. Azcona, and C. Macaya Old and new molecular mechanisms associated with platelet resistance to antithrombotics Pharm Res 27 2010 2365 2373
3. A.O. Maree, and D.J. Fitzgerald Variable platelet response to aspirin and clopidogrel in atherothrombotic disease Circulation 115 2007 2196 2207
4. M. Cattaneo The platelet P2Y receptor for adenosine diphosphate: congenital and drug-induced defects Blood 117 2011 2102 2112
5. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, and J.T. Brandt Cytochrome p-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
6. T. Simon, C. Verstuyft, M. Mary-Krause, L. Quteineh, E. Drouet, and N. Meneveau Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
7. D. Sibbing, T. Morath, J. Stegherr, S. Braun, W. Vogt, and M. Hadamitzky Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel Thromb Haemost 101 2009 714 719
8. M.L. O'Donoghue, E. Braunwald, E.M. Antman, S.A. Murphy, E.R. Bates, and Y. Rozenman Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials Lancet 374 2009 989 997
9. H.J. Bouman, E. Schomig, J.W. van Werkum, J. Velder, C.M. Hackeng, and C. Hirschhauser Paraoxonase-1 is a major determinant of clopidogrel efficacy Nat Med 17 2011 110 116
10. B. Goswami, D. Tayal, N. Gupta, and V. Mallika Paraoxonase: a multifaceted biomolecule Clin Chim Acta 410 2009 1 12
11. T. Bhattacharyya, S.J. Nicholls, E.J. Topol, R. Zhang, X. Yang, and D. Schmitt Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk JAMA 299 2008 1265 1276
12. G. Ferretti, T. Bacchetti, E. Marotti, and G. Curatola Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity Metabolism 52 2003 146 151
13. Y. Yano, T. Ohmori, S. Hoshide, S. Madoiwa, K. Yamamoto, and T. Katsuki Determinants of thrombin generation, fibrinolytic activity, and endothelial dysfunction in patients on dual antiplatelet therapy: involvement of factors other than platelet aggregability in Virchow's triad Eur Heart J 29 2008 1729 1738
14. T. Ohmori, Y. Yatomi, T. Nonaka, Y. Kobayashi, S. Madoiwa, and J. Mimuro Aspirin resistance detected with aggregometry cannot be explained by cyclooxygenase activity: involvement of other signaling pathway(s) in cardiovascular events of aspirin-treated patients J Thromb Haemost 4 2006 1271 1278
15. R.C. Becker, T.W. Meade, P.B. Berger, M. Ezekowitz, C.M. O'Connor, and D.A. Vorchheimer The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 776S 814S
16. R.S. Wright, J.L. Anderson, C.D. Adams, C.R. Bridges, D.E. Casey Jr., and S.M. Ettinger 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 57 2011 1920 1959
17. P.A. Gurbel, R.C. Becker, K.G. Mann, S.R. Steinhubl, and A.D. Michelson Platelet function monitoring in patients with coronary artery disease J Am Coll Cardiol 50 2007 1822 1834
18. T. Togawa, Y. Mukai, K. Ohata, T. Suzuki, and S. Tanabe Measurement of homocysteine thiolactone hydrolase activity using high-performance liquid chromatography with fluorescence detection and polymorphisms of paraoxonase in normal human serum J Chromatogr B Analyt Technol Biomed Life Sci 819 2005 67 72
19. K.A. Kim, W.K. Song, K.R. Kim, and J.Y. Park Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles J Clin Pharm Ther 35 2010 697 703
20. T. Jinnai, H. Horiuchi, T. Makiyama, J. Tazaki, T. Tada, and M. Akao Impact of CYP2C19 polymorphisms on the antiplatelet effect of clopidogrel in an actual clinical setting in Japan Circ J 73 2009 1498 1503
21. Z. Ding, S. Kim, R.T. Dorsam, J. Jin, and S.P. Kunapuli Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270 Blood 101 2003 3908 3914
22. D. Sibbing, W. Koch, S. Massberg, R.A. Byrne, J. Mehilli, and S. Schulz No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting Eur Heart J 32 2011 1605 1613